In today’s recent session, 1,647,857 shares of the Aerpio Pharmaceuticals, Inc.(NASDAQ:ARPO) have been traded, and its beta is 1.88. Most recently the company’s share price was $1.87, and it changed around -$0.07 or -0.04% from the last close, which brings the market valuation of the company to $85.07 Million. ARPO at last check was trading at a discount to its 52-week high of $2.31, offering almost -23.53% off that amount. The share price’s 52-week low was $0.42, which indicates that the recent value has risen by an impressive 77.54% since then. We note from Aerpio Pharmaceuticals, Inc.’s average daily trading volume that its 10-day average is 1.67 Million shares, with the 3-month average coming to 2.81 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Aerpio Pharmaceuticals, Inc. stock received a consensus recommendation rating of Overweight, based on a mean score of 2. If we narrow it down even further, the data shows that none out of 2 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, 1 recommended ARPO as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Aerpio Pharmaceuticals, Inc. is expected to report earnings per share of -$0.13 for the current quarter.

Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO): Trading Information Today

Although ARPO has been showing red trend so far today with a performance of -3.8% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2.12 on Friday, Feb 19 increased the stock’s daily price by 11.79%. The company’s shares are currently up 0.91% year-to-date, but still down -0.0922 over the last five days. On the other hand, Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) is 0.47% up in the 30-day period. We can see from the shorts that 1.24 Million shares have been sold at a short interest cover period of 0.44 day(s).

The consensus price target as assigned by Wall Street analysts is $1.75, which translates to bears needing to reduce their stock price by -6.42% from its current value. Analyst projections state that ARPO is forecast to be at a low of $1.5 and a high of $2. In order for the stock price to hit the forecast high, the stock would need to surge +6.95% from its current level, while the stock would need to crash -19.79% from its current level to reach the projected low.

Aerpio Pharmaceuticals, Inc. (ARPO) projections and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of 0%. Aerpio Pharmaceuticals, Inc. earnings are expected to decrease by -87.1% in 2021, but the outlook is negative 0% per year for the next five years.

Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO)’s Biggest Investors

Upon looking at major shareholders, it appears that insiders hold 16.18% of Aerpio Pharmaceuticals, Inc. shares, and 41.53% of them are in the hands of institutional investors. The stock currently has a share float of 49.55%. Aerpio Pharmaceuticals, Inc. stock is held by 34 institutions, with Orbimed Advisors LLC. being the largest institutional investor. By Sep 29, 2020, it held 12.8% of the shares, which is about 5.19 Million shares worth $7.79 Million.

Ikarian Capital, LLC, with 9.72% or 3.94 Million shares worth $5.91 Million as of Sep 29, 2020, holds the second largest percentage of outstanding shares.

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here